Both in Pharmaceuticals
GT Biopharma vs Adial Pharmaceuticals
Over the past year GTBP returned −52.6% and ADIL returned −50.1%; their daily moves had a correlation of 0.09.
GTBP −52.6% ADIL −50.1%Growth of $1, one year, split-adjusted
| Metric | GTBP | ADIL |
|---|---|---|
| Price | $6.88 | $4.15 |
| Market cap | $12.4M | $12.2M |
| Today | +1.10% | +2.72% |
| 1 month | −8.3% | −25.9% |
| 6 months | −33.6% | +142.7% |
| Year to date | −65.0% | −24.5% |
| 1 year | −64.2% | −51.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $28.7M |
| Dividend yield | — | — |
| Volatility (60d) | 955.7% | 113.4% |
| Short % of float | 0.8% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).